Dow AgroSciences

Dow AgroSciences | October 03, 2016

Monsanto Company (NYSE: MON) and Dow AgroSciences LLC, a wholly-owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced today that the companies have reached a non-exclusive global option and licensing agreement on Dow AgroSciences’ EXZACT™ Precision Technology® Platform for research and commercial development of new crop solutions across Monsanto Company’s research portfolio....

Dow AgroSciences | November 10, 2016

Chromatin Inc., an agriculture technology company, has signed an exclusive license agreement for unique sorghum genetic stocks developed by Agrigenetics Inc., an affiliate of Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW). Under the license agreement, Chromatin is deploying Dow AgroSciences’ sorghum technology to launch new, market-leading products in multiple key sorghum markets outside of the United States....

Dow AgroSciences | June 29, 2013

GMO Answers is a new website launched by The Council for Biotechnology Information, which includes BASF, Bayer CropScience, Dow AgroSciences, DuPont, Monsanto and Syngenta. The new initiative is aimed at answering questions from the public about GMOs and how food is produced....

Labiotech.eu | January 28, 2020

A Swiss research group has developed tiny plastic particles that could carry gene therapies to the center of the cell with less risk of getting attacked by the immune system than conventional gene therapies. The majority of gene therapies in use today are delivered to the DNA of target cells using viral vectors. While efficient at their job, viral vectors can risk triggering the immune system to destroy them. This can lead to the therapy becoming ineffective....